PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brcnresBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleBreast Cancer Research : BCR
 
Breast Cancer Res. 2010; 12(Suppl 1): P28.
Published online 2010 May 18. doi:  10.1186/bcr2525
PMCID: PMC2875590

Effect of intermittent versus continuous energy restriction on weight loss and breast cancer risk biomarkers

Introduction

The problems of adherence to energy restriction in humans are well known. Animal data suggest intermittent energy restriction (IER) is comparable with or better for preventing breast cancer than continuous restriction (CER).

Objective

To compare the feasibility and effectiveness of IER with CER for weight loss and improving insulin sensitivity and other markers of breast cancer risk.

Methods

Randomised comparison of a 25% energy restriction as IER (~2,266 kJ/day for 2 days/week) and CER (~6,276 kJ/day for 7 days/week) in 107 overweight or obese (mean ± SD body mass index = 30.6 ± 5.1 kg/m2) premenopausal women over 6 months. Weight, anthropometrics, blood markers for risk of breast cancer and other metabolic diseases, insulin resistance, oxidative stress markers, leptin, adiponectin, lipids, inflammatory markers (high-sensitivity C-reactive protein and sialic acid), insulin-like growth factor-I and insulin-like growth factor binding proteins, androgens, prolactin and menstrual cycle length were assessed at baseline, 1, 3 and 6 months.

Results

Eighteen subjects withdrew before 6 months (11 IER, seven CER). Last observation carried forward analysis showed IER and CER are equally effective for weight loss: mean (95% CI) weight change for IER was -6.4 (-7.9 to -4.8) kg vs. -5.6 (-6.9 to -4.4) kg for CER (P for difference between groups = 0.4). Both groups had significant and comparable improvements in disease risk markers; however, IER was significantly better than CER in reducing insulin resistance: mean (95% CI) change for IER was -28 (-37 to -17)% vs. -15 (-24 to -4)% for CER.

Conclusions

IER is as effective as CER for weight loss and biomarker change. Its additional beneficial effect on insulin sensitivity indicates that it may be an alternative approach for weight loss.


Articles from Breast Cancer Research : BCR are provided here courtesy of BioMed Central